Periscope Capital’s Translational Development Acquisition Corp TDAC Stock Holding History

Periscope Capital’s Portfolio TDAC Stock Details TDAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.34M	Sell	125,000 -175,000	-58%	-$1.87M	0.12%	216
2026 Q1	$3.17M	Sell	300,000 -100,090	-25%	-$1.05M	0.35%	89
2025 Q4	$4.19M	Hold	400,090	–	–	0.48%	46
2025 Q3	$4.14M	Buy	400,090 +200,090	+100%	+$2.07M	0.66%	47
2025 Q2	$2.06M	Hold	200,000	–	–	0.45%	71
2025 Q1	$2.02M	Buy	+200,000	New	+$2.01M	0.87%	45

Other funds holding TDAC

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

Kryger Capital London, United Kingdom $1.75B AUM 102.57% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return

HCM

Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

TCM

Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

AIMCA

Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.56% 1-Year Est. Return

Periscope Capital's TDAC Position: Q2 2026 in Review

Periscope Capital reduced its Translational Development Acquisition Corp (TDAC) stake by 58% in Q2 2026, selling an estimated $1.87M and leaving 125,000 shares worth $1.34M. The position accounts for 0.12% of the portfolio, ranked #216.

Periscope Capital first reported a position in TDAC in Q1 2025 and has held it in 6 quarters since. The position peaked at $4.19M in Q4 2025. 35 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.

Periscope Capital held 125,000 shares of Translational Development Acquisition Corp worth $1.34M as of Q2 2026.
Periscope Capital sold 175,000 Translational Development Acquisition Corp shares in Q2 2026, an estimated $1.87M.
Translational Development Acquisition Corp made up 0.12% of Periscope Capital's portfolio in Q2 2026, its #216 holding.
Periscope Capital first reported a position in Translational Development Acquisition Corp in Q1 2025 and has held it in 6 quarters since.
Periscope Capital's Translational Development Acquisition Corp position peaked at $4.19M in Q4 2025.
35 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.

Based on Periscope Capital's 13F filing for Q2 2026, filed 11 Aug 2026.